Polyethylene Glycol Nephrotoxicity Secondary to Prolonged High-Dose Intravenous Lorazepam
- 1 November 1995
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 29 (11) , 1110-1114
- https://doi.org/10.1177/106002809502901107
Abstract
Objective: To report a patient with a probable acute tubular necrosis (ATN) induced by chronic exposure to polyethylene glycol (PEG)-400 via long-term, massive dosage of intravenous lorazepam. Case Summary: A 57-year-old man with a history of alcohol abuse was admitted to the intensive care unit for acute respiratory failure. Lorazepam therapy was initiated in anticipation of alcohol withdrawal. Dosages up to 18 mg/h were required to provide adequate sedation and optimize ventilation. On day 43, the patient developed oliguric ATN of unknown etiology. The cumulative intravenous lorazepam dose was 4089 mg, equivalent to approximately 220 mL of PEG-400. Blood urea nitrogen concentrations followed a pattern that paralleled lorazepam dosage increases and decreases. Protein and granular casts were evident in urinalyses performed on days 12 and 29. The patient eventually experienced complete recovery. Discussion: ATN associated with intravenous PEG was last reported in 1959 in 6 of 32 patients receiving a cumulative PEG-300 dose of 120–200 mL over 3–5 days via an intravenous nitrofurantoin preparation. Two of the 6 patients died. Chronic administration of intravenous PEG to rabbits over a 5-week period has caused cloudy swelling of the renal tubular epithelium, increased blood urea concentrations, and death in some animals. Conclusions: ATN probably resulted from chronic PEG exposure via massive doses of lorazepam injection, possibly enhanced by concurrent administration of vancomycin.Keywords
This publication has 18 references indexed in Scilit:
- Sedation, Analgesia, and Paralysis in the Intensive Care UnitChest, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Adult Respiratory Distress SyndromeChest, 1992
- Use of Sedating Drugs and Neuromuscular Blocking Agents in Patients Requiring Mechanical Ventilation for Respiratory FailurePublished by American Medical Association (AMA) ,1991
- The HypermetabolismChest, 1989
- Ethylene Glycol IntoxicationArchives of internal medicine (1960), 1986
- Renal failure in the respiratory intensive care unitCritical Care Medicine, 1979
- Ethylene Glycol ToxicityAmerican Journal of Clinical Pathology, 1966
- Treatment of Chronic PyelonephritisA.M.A. Archives of Internal Medicine, 1959
- The toxicity of high molecular weight polyethylene glycols; chronic oral and parenteral administrationJournal of the American Pharmaceutical Association (Scientific ed.), 1947